Pilloxa Receives Funding from Vinnova!

25 May, 2018

Pilloxa is one of the companies awarded a grant from the Swedish innovation agency Vinnova. (article in swedish)

Out of 138 applicants, Pilloxa is one of the companies that was awarded funding from the Swedish innovation agency Vinnova. The funds from “Innovationsprojekt i företag” will be used to verify the business model of Pilloxa in a clinical context. For additional info see the following link (in swedish): Vinnova